DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Sheraton Pentagon City Hotel

2024 年 03 月 12 日 7:30 上午 - 2024 年 03 月 13 日 3:55 下午

900 South Orme Street, Arlington, VA 22204, USA

Advertising and Promotion Regulatory Affairs Conference

Explore the current state of compliance for marketing both biopharmaceuticals and medical devices.

Sponsored Session/Non-CE: Case Study Spotlight hosted by Hale Advisors: Preparing Promotional Review for the Shift to Omnichannel Marketing

Session Chair(s)

  Sponsored Sessions

Sponsored Sessions

United States

Pharmaceutical and biotechnology companies are shifting from multichannel to omnichannel marketing and modular content to drive better customer experience.

Join omnichannel marketing experts Zoë Dunn and Jason Cober, the Lead Project Manager for the FDA’s Office of Prescription Drug Promotion (OPDP), for an interactive discussion to demystify omnichannel and the complexities it introduces to promotional review.

Discover how you can amend your promotional review and OPDP submission processes and prepare review organizations to make a successful transition.

Coffee and a special local treat will be served!

Featured Topics:

  • How omnichannel differs from multichannel marketing
  • An example of omnichannel marketing in practice
  • The industry’s current state of omnichannel readiness
  • Critical components to support the variable and modular content review process
  • 2253 submissions and claims updates
  • How to prepare for a conversation with OPDP
  • Distinguishing variable content from modular content
  • The importance of a traceability matrix

Speaker(s)

Jason  Cober, MPA

Jason Cober, MPA

OPDP | OMP | CDER | FDA, United States

Lead Project Manager

Zoe  Dunn

Zoe Dunn

Hale Advisors, Inc., United States

President & CEO

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。